Thanks jq. I'm off to a bad start in my BIOD position but I think I will do fine as long as Phase 1 data due in 3Q this year is good on at least one of their two UFA insulin candidates. Should presumably be a low hurdle for Phase 1 success. I do expect BIOD is going to have to raise cash sometime soon, presumably after they report Phase 1 data.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.